Peptide & Compound Guide
At a glance
| Compound | DSIP |
|---|---|
| Type | Delta sleep-inducing peptide |
| U.S. regulatory context | Not FDA approved |
| Evidence level | Limited and mixed research |
| Research area | Sleep and neuroendocrine research |
What is DSIP?
Delta sleep-inducing peptide (DSIP) is a naturally occurring peptide that has been investigated in sleep and neuroendocrine research. The literature is limited and has not established it as a standard sleep treatment.
What does the research examine?
Sleep is influenced by many biological and behavioral factors. Small or older peptide studies should not be treated as equivalent to modern evidence for approved insomnia therapies.
What has not been established?
Mechanism, biomarker changes, animal findings and early clinical signals are not the same as proof that a compound safely improves meaningful health outcomes. Claims should be matched to the type, size and quality of evidence available.
Safety and regulatory context
Persistent sleep problems warrant assessment for conditions such as sleep apnea, insomnia, medication effects and other treatable causes.
Research sources
Use primary and authoritative sources when evaluating claims about this compound. Search results can change as new research is published.